Börsennachrichten
Aktuelle Finanznachrichten · Aktualisiert Jul 24, 2026
Wedbush nimmt die Bewertung von Sionna Therapeutics (SION) auf
Wedbush Initiates Coverage of Sionna Therapeutics (SION)
The panel is divided on Sionna's (SION) potential, with some seeing a niche market opportunity in non-responders to Vertex's Trikafta, …
KI-Rechenzentren beschäftigen sehr wenige Menschen: Was die Zahlen aussagen
AI data centers employ very few people: What the numbers how
The panel agrees that hyperscale data centers primarily benefit local economies through property tax revenue and fixed power demand, rather …
Das sagt die Wall Street über Intapp, Inc. (INTA)
Here’s What the Street Thinks About Intapp, Inc. (INTA)
The panelists agree that Intapp's growth in SaaS revenue and cloud ARR is impressive, but they are divided on its …
Jefferies bleibt bullish auf Surgery Partners (SGRY) nach Q1
Jefferies Remains Bullish on Surgery Partners (SGRY) Post Q1
Panelists express concern over SGRY's anemic volume growth, heavy debt load, and reliance on margin expansion for returns, casting doubt …
Warum BlackLine (BL) eine der besten Small-Cap-Aktien mit 10-fachem Potenzial ist
Why BlackLine (BL) is One of the Best Small Cap Stocks to Buy for 10x Potential
Despite progress in non-seat pricing, BlackLine faces significant challenges, including competition from larger ERP platforms, enterprise budget tightening, and the …
ProPetro Holding Corp. (PUMP) wird von Barclays nach Q1 auf Overweight upgrade
ProPetro Holding Corp. (PUMP) Gets Upgraded by Barclays Post Q1
The panel consensus is bearish, with concerns about PUMP's cash flow, margins, and the potential risks associated with the Caterpillar …
Carvana Aktienausblick: Ist Wall Street bullisch oder bärisch?
Carvana Stock Outlook: Is Wall Street Bullish or Bearish?
Despite impressive Q1 results, Carvana's stock performance and future EPS projections suggest deep skepticism about the sustainability of its growth. …
Hier ist, was Analysten über ADMA Biologics (ADMA) denken
Here’s What Analysts Think About ADMA Biologics (ADMA)
ADMA's Q1 2026 results show mixed performance with Asceniv's growth offset by Bivigam's significant decline. The company's pivot to a …
Barclays hebt das Preisziel für Innovex International (INVX) an, zitiert beste Sektoraufstellung in 20 Jahren
Barclays Lifts PT on Innovex International (INVX), Cites Best Sector Setup in 20 Years
The panel consensus is bearish on INVX, with key concerns being its limited scale, uncertain cash flow visibility, and potential …
Inhibrx Biosciences (INBX) gibt positive Zwischenergebnisse aus der Phase-2-Kohorte der HexAgon-Studie bekannt
Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study
The panelists agree that INBRX-106's 44% ORR in combination with pembrolizumab is notable but early-stage, with critical uncertainties around durability, …
Vermilion Energy Inc. (VET) gibt die finanziellen Ergebnisse für Q1 2026 bekannt
Vermilion Energy Inc. (VET) Announces Financial Results for Q1 2026
Panelists agree that Vermilion Energy (VET) has shown impressive operational discipline with significant debt reduction and production growth. However, they …
Was Analysten über Omnicell, Inc. (OMCL) sagen
Here is What Analysts Are Saying About Omnicell, Inc. (OMCL)
Panelists agree that Omnicell's transition to a SaaS-heavy model and Titan adoption are key to its future growth, but they …